Although they are not stroke-specific markers, such as interleukin 1 (Il-1), interleukin 6 (Il-6) or tumour necrosis factor-α (TNF-α), they suggest the existence of immunological activation in the course of the inflammatory process and tissue damage [58]. This evidence concerns the gene IL6 and stroke disorder.